NOVAST LABS FDA Approval ANDA 091234

ANDA 091234

NOVAST LABS

FDA Drug Application

Application #091234

Application Sponsors

ANDA 091234NOVAST LABS

Marketing Status

Prescription001

Application Products

001TABLET;ORAL-280.15MG;0.03MG0DESOGESTREL AND ETHINYL ESTRADIOLDESOGESTREL; ETHINYL ESTRADIOL

FDA Submissions

ORIG1AP2013-07-12
LABELING; LabelingSUPPL3AP2016-05-26STANDARD
LABELING; LabelingSUPPL5AP2017-08-09STANDARD
LABELING; LabelingSUPPL12AP2022-04-29STANDARD

Submissions Property Types

ORIG1Null15
SUPPL3Null15
SUPPL5Null7
SUPPL12Null7

TE Codes

001PrescriptionAB

CDER Filings

NOVAST LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91234
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"DESOGESTREL AND ETHINYL ESTRADIOL","activeIngredients":"DESOGESTREL; ETHINYL ESTRADIOL","strength":"0.15MG;0.03MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"DESOGESTREL AND ETHINYL ESTRADIOL","submission":"DESOGESTREL; ETHINYL ESTRADIOL","actionType":"0.15MG;0.03MG","submissionClassification":"TABLET;ORAL-28","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.